Longitudinal assessment of neuropathy in type 1 diabetes using novel ophthalmic markers (LANDMark)

Study design and baseline characteristics

Nicola Pritchard, Katie Edwards, Cirous Dehghani, Hassan Fadavi, Maria Jeziorska, Andrew Marshall, Ioannis N. Petropoulos, Georgios Ponirakis, Anthony W. Russell, Geoff P. Sampson, Ayda M. Shahidi, Sangeetha Srinivasan, Mitra Tavakoli, Dimitrios Vagenas, Rayaz Malik, Nathan Efron

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Aims: Corneal nerve morphology and corneal sensation threshold have recently been explored as potential surrogate markers for the evaluation of diabetic neuropathy. We present the baseline findings of the 'Longitudinal Assessment of Neuropathy in type 1 Diabetes using novel ophthalmic Markers'(LANDMark) study. Methods: The LANDMark study is a 4-year, two-site, natural history study of three participant groups: type 1 diabetes with neuropathy (T1W), type 1 diabetes without neuropathy (T1WO) and control participants without diabetes or neuropathy. All participants undergo a detailed annual assessment of neuropathy including corneal nerve parameters measured using corneal confocal microscopy and corneal sensitivity measured using non-contact corneal aesthesiometry. Results: 76 T1W, 166 T1WO and 154 control participants were enrolled into the study. Corneal sensation threshold was significantly higher (i.e., sensitivity was lower) in T1W (1.0±1.1mbars) than T1WO (0.7±0.7mbars) and controls (0.6±0.4mbars) (p<0.001), with no difference between T1WO and controls. Corneal nerve fibre length was lower in T1W (14.0±6.4mm/mm2) compared to T1WO (19.1±5.8mm/mm2) and controls (23.2±6.3mm/mm2) (p<0.001). Corneal nerve fibre length was lower in T1WO compared to controls. Conclusions: The LANDMark baseline findings confirm a reduction in corneal sensitivity only in Type 1 patients with neuropathy. However, corneal nerve fibre length is reduced in Type 1 patients without neuropathy with an even greater deficit in Type 1 patients with neuropathy.

Original languageEnglish
Pages (from-to)248-256
Number of pages9
JournalDiabetes Research and Clinical Practice
Volume104
Issue number2
DOIs
Publication statusPublished - 2014
Externally publishedYes

Fingerprint

Type 1 Diabetes Mellitus
Nerve Fibers
Diabetic Neuropathies
Natural History
Confocal Microscopy
Biomarkers

Keywords

  • Corneal confocal microscopy
  • Diabetic neuropathy
  • LANDMark study
  • Longitudinal trial
  • Non-contact corneal aesthesiometry

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Longitudinal assessment of neuropathy in type 1 diabetes using novel ophthalmic markers (LANDMark) : Study design and baseline characteristics. / Pritchard, Nicola; Edwards, Katie; Dehghani, Cirous; Fadavi, Hassan; Jeziorska, Maria; Marshall, Andrew; Petropoulos, Ioannis N.; Ponirakis, Georgios; Russell, Anthony W.; Sampson, Geoff P.; Shahidi, Ayda M.; Srinivasan, Sangeetha; Tavakoli, Mitra; Vagenas, Dimitrios; Malik, Rayaz; Efron, Nathan.

In: Diabetes Research and Clinical Practice, Vol. 104, No. 2, 2014, p. 248-256.

Research output: Contribution to journalArticle

Pritchard, N, Edwards, K, Dehghani, C, Fadavi, H, Jeziorska, M, Marshall, A, Petropoulos, IN, Ponirakis, G, Russell, AW, Sampson, GP, Shahidi, AM, Srinivasan, S, Tavakoli, M, Vagenas, D, Malik, R & Efron, N 2014, 'Longitudinal assessment of neuropathy in type 1 diabetes using novel ophthalmic markers (LANDMark): Study design and baseline characteristics', Diabetes Research and Clinical Practice, vol. 104, no. 2, pp. 248-256. https://doi.org/10.1016/j.diabres.2014.02.011
Pritchard, Nicola ; Edwards, Katie ; Dehghani, Cirous ; Fadavi, Hassan ; Jeziorska, Maria ; Marshall, Andrew ; Petropoulos, Ioannis N. ; Ponirakis, Georgios ; Russell, Anthony W. ; Sampson, Geoff P. ; Shahidi, Ayda M. ; Srinivasan, Sangeetha ; Tavakoli, Mitra ; Vagenas, Dimitrios ; Malik, Rayaz ; Efron, Nathan. / Longitudinal assessment of neuropathy in type 1 diabetes using novel ophthalmic markers (LANDMark) : Study design and baseline characteristics. In: Diabetes Research and Clinical Practice. 2014 ; Vol. 104, No. 2. pp. 248-256.
@article{8c70923cd34044799ad58f92981b17aa,
title = "Longitudinal assessment of neuropathy in type 1 diabetes using novel ophthalmic markers (LANDMark): Study design and baseline characteristics",
abstract = "Aims: Corneal nerve morphology and corneal sensation threshold have recently been explored as potential surrogate markers for the evaluation of diabetic neuropathy. We present the baseline findings of the 'Longitudinal Assessment of Neuropathy in type 1 Diabetes using novel ophthalmic Markers'(LANDMark) study. Methods: The LANDMark study is a 4-year, two-site, natural history study of three participant groups: type 1 diabetes with neuropathy (T1W), type 1 diabetes without neuropathy (T1WO) and control participants without diabetes or neuropathy. All participants undergo a detailed annual assessment of neuropathy including corneal nerve parameters measured using corneal confocal microscopy and corneal sensitivity measured using non-contact corneal aesthesiometry. Results: 76 T1W, 166 T1WO and 154 control participants were enrolled into the study. Corneal sensation threshold was significantly higher (i.e., sensitivity was lower) in T1W (1.0±1.1mbars) than T1WO (0.7±0.7mbars) and controls (0.6±0.4mbars) (p<0.001), with no difference between T1WO and controls. Corneal nerve fibre length was lower in T1W (14.0±6.4mm/mm2) compared to T1WO (19.1±5.8mm/mm2) and controls (23.2±6.3mm/mm2) (p<0.001). Corneal nerve fibre length was lower in T1WO compared to controls. Conclusions: The LANDMark baseline findings confirm a reduction in corneal sensitivity only in Type 1 patients with neuropathy. However, corneal nerve fibre length is reduced in Type 1 patients without neuropathy with an even greater deficit in Type 1 patients with neuropathy.",
keywords = "Corneal confocal microscopy, Diabetic neuropathy, LANDMark study, Longitudinal trial, Non-contact corneal aesthesiometry",
author = "Nicola Pritchard and Katie Edwards and Cirous Dehghani and Hassan Fadavi and Maria Jeziorska and Andrew Marshall and Petropoulos, {Ioannis N.} and Georgios Ponirakis and Russell, {Anthony W.} and Sampson, {Geoff P.} and Shahidi, {Ayda M.} and Sangeetha Srinivasan and Mitra Tavakoli and Dimitrios Vagenas and Rayaz Malik and Nathan Efron",
year = "2014",
doi = "10.1016/j.diabres.2014.02.011",
language = "English",
volume = "104",
pages = "248--256",
journal = "Diabetes Research and Clinical Practice",
issn = "0168-8227",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Longitudinal assessment of neuropathy in type 1 diabetes using novel ophthalmic markers (LANDMark)

T2 - Study design and baseline characteristics

AU - Pritchard, Nicola

AU - Edwards, Katie

AU - Dehghani, Cirous

AU - Fadavi, Hassan

AU - Jeziorska, Maria

AU - Marshall, Andrew

AU - Petropoulos, Ioannis N.

AU - Ponirakis, Georgios

AU - Russell, Anthony W.

AU - Sampson, Geoff P.

AU - Shahidi, Ayda M.

AU - Srinivasan, Sangeetha

AU - Tavakoli, Mitra

AU - Vagenas, Dimitrios

AU - Malik, Rayaz

AU - Efron, Nathan

PY - 2014

Y1 - 2014

N2 - Aims: Corneal nerve morphology and corneal sensation threshold have recently been explored as potential surrogate markers for the evaluation of diabetic neuropathy. We present the baseline findings of the 'Longitudinal Assessment of Neuropathy in type 1 Diabetes using novel ophthalmic Markers'(LANDMark) study. Methods: The LANDMark study is a 4-year, two-site, natural history study of three participant groups: type 1 diabetes with neuropathy (T1W), type 1 diabetes without neuropathy (T1WO) and control participants without diabetes or neuropathy. All participants undergo a detailed annual assessment of neuropathy including corneal nerve parameters measured using corneal confocal microscopy and corneal sensitivity measured using non-contact corneal aesthesiometry. Results: 76 T1W, 166 T1WO and 154 control participants were enrolled into the study. Corneal sensation threshold was significantly higher (i.e., sensitivity was lower) in T1W (1.0±1.1mbars) than T1WO (0.7±0.7mbars) and controls (0.6±0.4mbars) (p<0.001), with no difference between T1WO and controls. Corneal nerve fibre length was lower in T1W (14.0±6.4mm/mm2) compared to T1WO (19.1±5.8mm/mm2) and controls (23.2±6.3mm/mm2) (p<0.001). Corneal nerve fibre length was lower in T1WO compared to controls. Conclusions: The LANDMark baseline findings confirm a reduction in corneal sensitivity only in Type 1 patients with neuropathy. However, corneal nerve fibre length is reduced in Type 1 patients without neuropathy with an even greater deficit in Type 1 patients with neuropathy.

AB - Aims: Corneal nerve morphology and corneal sensation threshold have recently been explored as potential surrogate markers for the evaluation of diabetic neuropathy. We present the baseline findings of the 'Longitudinal Assessment of Neuropathy in type 1 Diabetes using novel ophthalmic Markers'(LANDMark) study. Methods: The LANDMark study is a 4-year, two-site, natural history study of three participant groups: type 1 diabetes with neuropathy (T1W), type 1 diabetes without neuropathy (T1WO) and control participants without diabetes or neuropathy. All participants undergo a detailed annual assessment of neuropathy including corneal nerve parameters measured using corneal confocal microscopy and corneal sensitivity measured using non-contact corneal aesthesiometry. Results: 76 T1W, 166 T1WO and 154 control participants were enrolled into the study. Corneal sensation threshold was significantly higher (i.e., sensitivity was lower) in T1W (1.0±1.1mbars) than T1WO (0.7±0.7mbars) and controls (0.6±0.4mbars) (p<0.001), with no difference between T1WO and controls. Corneal nerve fibre length was lower in T1W (14.0±6.4mm/mm2) compared to T1WO (19.1±5.8mm/mm2) and controls (23.2±6.3mm/mm2) (p<0.001). Corneal nerve fibre length was lower in T1WO compared to controls. Conclusions: The LANDMark baseline findings confirm a reduction in corneal sensitivity only in Type 1 patients with neuropathy. However, corneal nerve fibre length is reduced in Type 1 patients without neuropathy with an even greater deficit in Type 1 patients with neuropathy.

KW - Corneal confocal microscopy

KW - Diabetic neuropathy

KW - LANDMark study

KW - Longitudinal trial

KW - Non-contact corneal aesthesiometry

UR - http://www.scopus.com/inward/record.url?scp=84898820569&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898820569&partnerID=8YFLogxK

U2 - 10.1016/j.diabres.2014.02.011

DO - 10.1016/j.diabres.2014.02.011

M3 - Article

VL - 104

SP - 248

EP - 256

JO - Diabetes Research and Clinical Practice

JF - Diabetes Research and Clinical Practice

SN - 0168-8227

IS - 2

ER -